The SOLIRIS brand, founded in 2005 (United States), from 585 sister brands and 17478 competing brands. SOLIRIS is owned by ASTRAZENECA, listed on the stock exchange of London The ISIN, the company's International Securities Identification Number, is GB0009895292. SOLIRIS is part of the Drug Manufacturers activity sector.